Marshall Wace North America’s Silicon Laboratories SLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-75,630
Closed -$10.7M 1743
2021
Q1
$10.7M Buy
+75,630
New +$10.8M 0.04% 378
2020
Q4
Sell
-20,750
Closed -$2.03M 1557
2020
Q3
$2.03M Buy
+20,750
New +$2.09M 0.01% 586
2020
Q2
Sell
-964
Closed -$82K 1455
2020
Q1
$82K Sell
964
-17,803
-95% -$1.77M ﹤0.01% 1023
2019
Q4
$2.18M Buy
+18,767
New +$2.06M 0.01% 557
2019
Q1
Sell
-19,502
Closed -$1.54M 1874
2018
Q4
$1.54M Buy
+19,502
New +$1.62M 0.01% 500
2018
Q2
Sell
-26,251
Closed -$2.36M 1654
2018
Q1
$2.36M Buy
+26,251
New +$2.48M 0.01% 768
2017
Q3
Sell
-3,565
Closed -$242K 1475
2017
Q2
$242K Buy
+3,565
New +$258K ﹤0.01% 1193

Other funds holding SLAB

Marshall Wace North America's SLAB Position: Q2 2021 in Review

Marshall Wace North America sold out of Silicon Laboratories (SLAB) in Q2 2021, closing a stake of 75,630 shares — an estimated $10.7M sold.

Marshall Wace North America first reported a position in SLAB in Q2 2017 and held it in 7 quarters. The position peaked at $10.7M in Q1 2021. 262 funds tracked by Wall St. Rank hold SLAB as of Q2 2021.

  • Marshall Wace North America reported no remaining Silicon Laboratories position as of Q2 2021 after selling out during the quarter.
  • Marshall Wace North America sold 75,630 Silicon Laboratories shares in Q2 2021, an estimated $10.7M.
  • Marshall Wace North America first reported a position in Silicon Laboratories in Q2 2017 and held it in 7 quarters.
  • Marshall Wace North America's Silicon Laboratories position peaked at $10.7M in Q1 2021.
  • 262 funds tracked by Wall St. Rank held Silicon Laboratories as of Q2 2021.

Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.